col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


73 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Hypertension Research
  original article Date Title Authors   All Authors
1 [GO] 2026―May―26 Do angiotensin-converting enzyme inhibitors reduce the risk of death in COVID-19? Yes Mykola Khalangot
2 [GO] 2026―Mar―30 Trends of new diagnosis and treatment initiation of hypertension during the COVID-19 pandemic in Korea Jaeyong Lee, Ari Lee, Moses Song, Jiyen Han, Kyoung Hwa Ha, Hyeok-Hee Lee, et al. (+3)
3 [GO] 2026―Feb―27 Response to correspondence on “Prevalence of hypertension and related factors among suspected hypertensive medical personnel during COVID-19 vaccination” Sittichai Khamsai, Nat Leelawiwat, Praew Kotruchin, Wantin Sribenjalux, Phitphiboon Deawtrakulchai, Somchai Ruangwannasak, Kittisak Sawanyawisuth
4 [GO] 2026―Feb―06 Comment on “Prevalence of hypertension and related factors among suspected hypertensive medical personnel during COVID-19 vaccination” Fengyu Chen, Chunming Zhang, Kan Kan, Zejun Xue, Jun Zhang
5 [GO] 2026―Jan―14 “Implementation Hypertension” in the pandemic era: unmasking white-coat effects in healthcare workers Emi Ushigome, Michiaki Fukui
6 [GO] 2025―Dec―02 Response to the Letter Regarding Our Editorial: “Impact of SARS-CoV-2 variants on viral infectivity and the role of the Renin-Angiotensin-Aldosterone system” Yasushi Matsuzawa, Kenichi Tsujita
7 [GO] 2025―Dec―02 Renin-angiotensin-aldosterone system inhibitors - why they won’t help in COVID-19 Chia Siang Kow, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
8 [GO] 2025―Oct―14 Prevalence of hypertension and related factors among suspected hypertensive medical personnel during COVID-19 vaccination Sittichai Khamsai, Nat Leelawiwat, Praew Kotruchin, Wantin Sribenjalux, Phitphiboon Deawtrakulchai, Somchai Ruangwannasak, Kittisak Sawanyawisuth
9 [GO] 2025―Oct―08 Comment on “Indirect effect of the COVID-19 pandemic on cardiovascular diseases incidence, mortality, and healthcare use among patients with hypertension but without SARS-CoV-2 infection in Hong Kong” Hinpetch Daungsupawong, Viroj Wiwanitkit
10 [GO] 2025―Oct―03 Correction: Effect of the renin-angiotensin-aldosterone system inhibitors on time to nucleic acid negative conversion in hypertensive patients with SARS-CoV-2 omicron infection: a propensity score matching study Ru Wen, Jingwen Li, Fengxi Chen, Jian Liu, Peng Xu, Mengfei Li, et al. (+3)
11 [GO] 2025―May―23 Indirect effect of the COVID-19 pandemic on cardiovascular diseases incidence, mortality, and healthcare use among patients with hypertension but without SARS-CoV-2 infection in Hong Kong: an interrupted time series analysis Zhuoran Hu, Yuk Kam Yau, Jianchao Quan, Karen Ann Grépin, Ivy Lynn Mak, Gary Kui Kai Lau, et al. (+6)
12 [GO] 2025―Jan―28 Impact of SARS-CoV-2 variants on viral infectivity and the role of the renin-angiotensin-aldosterone system Yasushi Matsuzawa, Kenichi Tsujita
13 [GO] 2025―Jan―08 Association between equivalized annual household income and regular medical visits for hypertensive patients since the COVID-19 outbreak Maya Toyama, Michihiro Satoh, Hideaki Hashimoto, Yutaro Iwabe, Takahito Yagihashi, Shingo Nakayama, et al. (+5)
14 [GO] 2024―Dec―23 Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam
15 [GO] 2024―Dec―23 Response to the correspondence: Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing Fumiki Yoshihara
16 [GO] 2024―Nov―06 Effect of the renin-angiotensin-aldosterone system inhibitors on time to nucleic acid negative conversion in hypertensive patients with SARS-CoV-2 omicron infection: a propensity score matching study Ru Wen, Jinwen Li, Fengxi Chen, Jian Liu, Peng Xu, Mengfei Li, et al. (+3)
17 [GO] 2024―Aug―01 Shadow left by COVID-19 pandemic on the future Hisashi Kai
18 [GO] 2024―Jul―01 The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks Takahiro Okumura, Toyoaki Murohara
19 [GO] 2024―Jun―03 The trends of antihypertensive drug prescription based on the Japanese national data throughout the COVID-19 pandemic period Shotaro Natsume, Michihiro Satoh, Takahisa Murakami, Masato Sasaki, Hirohito Metoki
20 [GO] 2024―Apr―26 Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital Fumiki Yoshihara, Yasushi Matsuzawa, Kiyomasa Nakatsuka, Jin Kirigaya, Ichiro Takeuchi, Kazuo Kimura, et al. (+26)
21 [GO] 2024―Jan―31 The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID Chisa Matsumoto
22 [GO] 2023―Dec―25 Association between blood pressure and COVID-19 severity Fumiki Yoshihara
23 [GO] 2023―Dec―04 Uninterrupted medical care against disasters and pandemics Tomomi Hasebe, Naoyuki Hasebe
24 [GO] 2023―Nov―29 Mitigating secondary disaster triggered by fear of COVID-19: the role of professional medical societies Yasushi Matsuzawa, Kenichi Tsujita
25 [GO] 2023―Nov―17 Calcium channel blockers may reduce the development of long COVID in females Takuya Ozawa, Ryusei Kimura, Hideki Terai, Ryo Takemura, Ho Namkoong, Masahiro Kondo, et al. (+15)
26 [GO] 2023―Nov―02 Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force Kaori Sakurai, Shotaro Chubachi, Takanori Asakura, Ho Namkoong, Hiromu Tanaka, Shuhei Azekawa, et al. (+20)
27 [GO] 2023―Oct―23 The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients Qiaoqiao Zhou, Lei Zhang, Yanming Dong, Yuan Wang, Bin Zhang, Shiyi Zhou, et al. (+3)
28 [GO] 2023―Jul―18 Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study Ryosuke Miura, Kouji Okada
29 [GO] 2023―Jul―13 Reply to: Microvascular hypertensive disease, long COVID, and end-organ pathology Chisa Matsumoto
30 [GO] 2023―Jul―13 Microvascular hypertensive disease, Long COVID, and end-organ pathology Nevio Cimolai
31 [GO] 2023―Jun―12 Correction to: Preeclampsia and COVID-19 in Afghanistan: additional burden on Afghan pregnant women’s health Nooria Mohammady, Sayed Hamid Mousavi, Fatema Rezaie, Huma Homam
32 [GO] 2023―May―26 Preeclampsia and COVID-19 in Afghanistan: additional burden on Afghan pregnant women’s health Nooria Mohammady, Sayed Hamid Mousavi, Fatima Rezaie, Huma Homam
33 [GO] 2023―Mar―30 Hypertension management before and under the COVID-19 pandemic: lessons and future directions Yoichi Nozato, Koichi Yamamoto, Hiromi Rakugi
34 [GO] 2023―Feb―27 Reply to: Hypertension and severe COVID-19 Shigeru Shibata, Kei Asayama
35 [GO] 2023―Feb―27 Hypertension and severe COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
36 [GO] 2022―Dec―27 Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19 Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, Satoshi Morimoto, Masaki Mogi, Koichi Yamamoto, et al. (+10)
37 [GO] 2022―Dec―23 COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19 Shigeru Shibata, Kazuo Kobayashi, Masami Tanaka, Kei Asayama, Eiichiro Yamamoto, Hironori Nakagami, et al. (+10)
38 [GO] 2022―Nov―15 Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension Kengo Azushima, Hiromichi Wakui, Kouichi Tamura
39 [GO] 2022―Oct―24 Therapeutic target and clinical impact of day-to-day blood pressure variability in hypertensive patients with covid-19 Gusti Ngurah Prana Jagannatha, A. A. A. Dwi Adelia Yasmin, I. Wayan Agus Surya Pradnyana, Stanly Kamardi, I. Gusti Bagus Mulia Agung Pradnyaandara, Elinardo Enrique Pangkahila, et al. (+2)
40 [GO] 2022―Oct―14 The relationship between changes in exercise habits and psychosomatic activities in older hypertensive patients during the COVID-19 pandemic Yukiko Yasunobe, Hiroshi Akasaka, Koichi Yamamoto, Yuri Onishi, Tomohiro Minami, Shino Yoshida, Hiromi Rakugi
41 [GO] 2022―Sep―05 Effect of COVID-19 pandemic on seasonal cardiovascular mortality in Japan, and Asian evidence Kazuomi Kario, Masaki Mogi, Satoshi Hoshide
42 [GO] 2022―Jul―15 Severe COVID-19 and preexisting hypertension: a matter of age? Osamu Yamazaki, Shigeru Shibata
43 [GO] 2022―Jun―20 Time-series analysis of blood pressure changes after the guideline update in 2019 and the coronavirus disease pandemic in 2020 using Japanese longitudinal data Michihiro Satoh, Takahisa Murakami, Taku Obara, Hirohito Metoki
44 [GO] 2022―May―18 Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19 Yasushi Matsuzawa, Kazuo Kimura, Hisao Ogawa, Kouichi Tamura
45 [GO] 2022―Mar―29 The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19 Ewan McFarlane, Marijke Linschoten, Folkert W. Asselbergs, Peter S. Lacy, Dawid Jedrzejewski, Bryan Williams
46 [GO] 2022―Mar―10 The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness Dimitrios Terentes-Printzios, Vasiliki Gardikioti, Eirini Solomou, Eleni Emmanouil, Ioanna Gourgouli, Panagiotis Xydis, et al. (+8)
47 [GO] 2022―Feb―28 Is COVID-19 vaccination beneficial or harmful to endothelial cells? Masaki Mogi
48 [GO] 2022―Feb―18 Anxiety and hypertension in the COVID-19 era: how is the central autonomic network linked? Michiaki Nagai, Masaya Kato, Dote Keigo
49 [GO] 2022―Jan―21 Anxiety, home blood pressure monitoring, and cardiovascular events among older hypertension patients during the COVID-19 pandemic Shuyuan Zhang, Yixuan Zhong, Lixin Wang, Xinhua Yin, Yufeng Li, Yunlan Liu, et al. (+14)
50 [GO] 2021―Dec―24 Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan Kazuo Kobayashi, Keiichi Chin, Shinichi Umezawa, Shun Ito, Hareaki Yamamoto, Shiro Nakano, et al. (+3)
51 [GO] 2021―Dec―17 How to deal with hypertension in the COVID-19 era-the impact “ON” and “OF” hypertension Mari Ishida
52 [GO] 2021―Dec―02 Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study Fabiana G. A. M. Feitosa, Audes D. M. Feitosa, Annelise M. G. Paiva, Marco A. Mota-Gomes, Weimar S. Barroso, Roberto D. Miranda, et al. (+6)
53 [GO] 2021―Nov―30 Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients Prakash G. Kulkarni, Amul Sakharkar, Tanushree Banerjee
54 [GO] 2021―Nov―18 Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry Alberto Cereda, Marco Toselli, Anna Palmisano, Davide Vignale, Arif Khokhar, Gianluca Campo, et al. (+14)
55 [GO] 2021―Nov―09 Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
56 [GO] 2021―Jun―08 Therapeutic vaccine for chronic diseases after the COVID-19 Era Hironori Nakagami, Hiroki Hayashi, Munehisa Shimamura, Hiromi Rakugi, Ryuichi Morishita
57 [GO] 2021―May―20 Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials Chia Siang Kow, Long Chiau Ming, Syed Shahzad Hasan
58 [GO] 2021―Feb―03 Estrogen receptors are linked to angiotensin-converting enzyme 2 (ACE2), ADAM metallopeptidase domain 17 (ADAM-17), and transmembrane protease serine 2 (TMPRSS2) expression in the human atrium: insights into COVID-19 Hao Wang, Xuming Sun, Jessica L. VonCannon, Neal D. Kon, Carlos M. Ferrario, Leanne Groban
59 [GO] 2021―Jan―20 Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with COVID-19: a review Nitalia Naidoo, Jagidesa Moodley, Thajasvarie Naicker
60 [GO] 2021―Jan―06 The association between blood pressure levels and mortality in critically ill patients with COVID-19 in Wuhan, China: a case-series report Li Geng, Chao He, Hao Kan, Ka Zhang, Aiqin Mao, Chi Zhang, et al. (+7)
61 [GO] 2021―Jan―05 Further promotion of “the JSH plan for the future” conscious of new normal after/with COVID-19: message from the new president of the Japanese Society of Hypertension Hiromi Rakugi
62 [GO] 2020―Nov―02 The pivotal role of the angiotensin-II-NF-κB axis in the development of COVID-19 pathophysiology Hiroshi Okamoto, Naomi Ichikawa
63 [GO] 2020―Aug―27 Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China Jinjun Ran, Ying Song, Zian Zhuang, Lefei Han, Shi Zhao, Peihua Cao, et al. (+6)
64 [GO] 2020―Aug―21 Renin-angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study Yasushi Matsuzawa, Hisao Ogawa, Kazuo Kimura, Masaaki Konishi, Jin Kirigaya, Kazuki Fukui, et al. (+8)
65 [GO] 2020―Jul―31 Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 Shigeru Shibata, Hisatomi Arima, Kei Asayama, Satoshi Hoshide, Atsuhiro Ichihara, Toshihiko Ishimitsu, et al. (+11)
66 [GO] 2020―Jun―18 A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension Hiroshi Itoh
67 [GO] 2020―Jun―10 SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs Michele M. Ciulla
68 [GO] 2020―Jun―01 COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study Songjiang Huang, Jianwen Wang, Fen Liu, Jiacheng Liu, Guijuan Cao, Chongtu Yang, et al. (+4)
69 [GO] 2020―May―22 Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system? François Silhol, Gabrielle Sarlon, Jean-Claude Deharo, Bernard Vaïsse
70 [GO] 2020―May―20 Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19 Masato Furuhashi, Norihito Moniwa, Hideki Takizawa, Nobuyuki Ura, Kazuaki Shimamoto
71 [GO] 2020―Apr―30 A novel COVID-19 and its effects on cardiovascular disease Arumugam Paramasivam, Jayaseelan Vijayashree Priyadharsini, Subramanian Raghunandhakumar, Perumal Elumalai
72 [GO] 2020―Apr―27 Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19 Hisashi Kai, Mamiko Kai
73 [GO] 2020―Mar―30 Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension Gang Li, Rui Hu, Xuejiao Zhang
 [1] 

73 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec